Projects per year
Personal profile
Personal profile
Dr. Butler graduated from Georgetown University School of Medicine in Washington, D.C. in 1982. He started his residency at Wilford Hall USAF Medical Center in San Antonio, Texas in 1982 and then completed his residency as Chief Resident at Stanford University Medical Center in 1986. After completing his postdoctoral training in 1987, Dr. Butler returned to the Wilford Hall USAF Medical Center where he became both the Chief of Radiation Oncology and the Chief of Brachytherapy. He also joined the faculty at The University of Texas Health Science Center at San Antonio as a Clinical Assistant Professor that same year. Dr. Butler would later join the Baylor College of Medicine where he would eventually become a full professor and the Chief of Radiation Oncology for both the medical school and the VA Hospital. He became the Medical Director of Radiation Oncology at Methodist in 1991, and received his faculty appointment at the Weill Medical School in 2006. He became Chair of Radiation Oncology at Houston Methodist in 2008. In 2016, Dr. Butler was named the Jim and Joan Harrell Chair in Radiation Oncology.
Research interests
Dr. Butler’s research centers on preclinical and clinical studies that combine radiation therapy and gene therapy for the treatment of prostate cancer. In recent years, he has extended these successful studies to other cancers, notably pancreatic cancer. His research interests also include three-dimensional reconstruction of body organs to assist in better localization of radiation therapy.
Education/Academic qualification
Radiation Therapy, Residency, Stanford School of Medicine
Jul 1 1984 → Jun 30 1987
Award Date: Jun 30 1987
MD, Georgetown University
… → May 31 1982
Award Date: May 31 1982
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Care
Free-text keywords
- Prostate cancer
- Pancreatic cancer
- Radiation therapy
- Gene therapy
- Computer visualization techniques
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
HIGH DOSE RATE BRACHYTHERAPY PRIOR TO ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH SELECTIVE ADJUVANT ADVANCED ANDROGEN BLOCKADE FOR LOCALIZED HIGH-RISK PROSTATE CANCER (NEOHDR-B)
Farach, A. M. (PI), Butler, E. B. (Key Personnel), Mathur, S. (Key Personnel), Miles, B. J. (Key Personnel), Satkunasivam, R. (Key Personnel) & Teh, B. S. (Key Personnel)
12/23/24 → …
Project: Clinical Trial
-
Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy
Baskin, D. S. (PI), Butler, E. B. (Key Personnel), Guan, J. (Key Personnel) & Teh, B. S. (Key Personnel)
1/15/18 → …
Project: Clinical Trial
-
Phase I-II Study Evaluating HSV-tk + Valacyclovir Gene Therapy Combination with Radiotherapy and Chemotherapy for Recurrent Glioblastoma Multiforme
Baskin, D. S. (PI), Butler, E. B. (Key Personnel), Guan, J. (Key Personnel) & Teh, B. S. (Key Personnel)
8/23/17 → …
Project: Clinical Trial
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Butler, E. B. (CoI), Darcourt, J. (CoI), Farach, A. M. (CoI), Kamat, A. A. (CoI), Shkedy, C. (CoI), Singh, M. (CoI) & Suri, A. (CoI)
3/1/14 → 2/28/39
Project: Non Profit
-
A PHASE III TRIAL EVALUATING THE ADDITION OF TRASTUZUMAB TO TRIMODALITY TREATMENT OF HER2-OVEREXPRESSING ESOPHAGEAL ADENOCARCINOMA
Butler, E. B. (Project Director), Kim, M. P. (Project Director) & Teh, B. S. (Project Director)
7/24/13 → 7/23/38
Project: Non Profit
-
HDR brachytherapy salvage for nodular prostate fossa recurrence: A mechanistic review and initial report of clinical outcomes
Andring, L. M., Krc, R. F., Paradise, E., Li, B., Baghwala, A., Miles, B., Satkunasivam, R., Kaushik, D., Pino, R., Teh, B. S., Butler, E. B. & Farach, A. M., May 1 2025, In: Brachytherapy. 24, 3, p. 404-412 9 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Oncotype DX Recurrence Score Predicts Survival in Invasive Micropapillary Breast Carcinoma: A National Cancer Database Analysis
Haider, A. J., Kazmi, M., Chang, K., Haque, W. M., Polychronopoulou, E., Cummock, J. S., Hatch, S. S., Farach, A. M., Parvathaneni, U., Butler, E. B. & Teh, B. S., Oct 5 2025, In: Current Oncology. 32, 10, 559.Research output: Contribution to journal › Article › peer-review
Open Access -
Radiosurgery for Intracranial Meningiomas: A Review of Anatomical Challenges and an Update on the Evidence
Goldman, M. J., Teh, B. S., Lo, S. S., Butler, E. B. & Baskin, D. S., Jan 2025, In: Cancers. 17, 1, 45.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Staged I-125 Eye Plaque Brachytherapy for the Treatment of Large Uveal Melanoma: A Single Institution Experience
Tran, K., Schefler, A. C., Nguyen, L. N., Olek, D., Wang, H. C., Pino, R., Butler, E. B. & Teh, B. S., 2025, (Accepted/In press) In: Practical Radiation Oncology.Research output: Contribution to journal › Article › peer-review
-
Utilization and Outcomes of the 21‐Gene Recurrence Score in pN2 Breast Cancer Patients
Haque, W., Verma, V., Mangalampalli, N., Schwartz, M. R., Butler, E. B., Sun, K., Jain, D., Arentz, C., Ramakrishnan, A. & Teh, B. S., Mar 2025, In: Anticancer Research. 45, 3, p. 1055-1061 7 p.Research output: Contribution to journal › Article › peer-review